Aitana is a postdoctoral researcher currently funded by the UK Dementia Research Institute. She has recently been awarded a Race Against Dementia fellowship for the next five years. She has a BSc in Biology from the University of Alicante and a MSc and PhD in Neuroscience from the Universidad Miguel Hernandez de Elche at Instituto de Neurociencias de Alicante. Her PhD investigated novel biomarkers for Alzheimer’s Disease during which time she spent 3 months at the University of Gothenburg in Sweden learning about the development of ELISAs. After completing her PhD, she moved to London and started her first postdoc at the UK Dementia Research Institute where her main project was to develop fluid biomarkers of microglial activation. She now works in the Biomarker Lab at the UK DRI helping to develop novel biomarkers for FTD. Her fellowship work will focus on blood biomarkers through the study of exosomes.
- AAIC 2020 (Virtual meeting, July 2020): Lipid mediators in frontotemporal dementia – novel insights into neuroinflammation
- AAIC 2023 (Amsterdam, July 2023): Targeted proteomic search reveals new actors in the synaptic and lysosomal dysfunction in genetic FTD, a GENFI study
- AAIC 2021 (virtual, July 2021): Differential synaptic marker involvement in the different genetic forms of frontotemporal dementia
- Vesicle Trafficking and Pathways to Neurodegeneration 2021 (virtual, May 2021): Differential synaptic marker involvement in the different genetic forms of frontotemporal dementia – see video description here
- BNA 2021 (virtual, April 2021): Differential chemokine changes are seen in the different variants of primary progressive aphasia – see video description here
- ARUK 2021 (virtual, March 2021): Differential chemokine changes are seen in the different variants of primary progressive aphasia
- Differential chemokine alteration in the variants of primary progressive aphasia—a role for neuroinflammation.
- J Alzheimers Dis. 2021 [Epub ahead of Print].
